{"organizations": [], "uuid": "76e69bb4ef75dec72b2f1359f9c597bd67eefc13", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/credit-suisse-gp-healthcare-israel/credit-suisse-commits-250-mln-to-israeli-healthcare-fund-idUSL5N1SM7SH", "country": "US", "domain_rank": 408, "title": "Credit Suisse commits $250 mln to Israeli healthcare fund", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-16T08:00:00.000+03:00", "replies_count": 0, "uuid": "76e69bb4ef75dec72b2f1359f9c597bd67eefc13"}, "author": "", "url": "https://www.reuters.com/article/credit-suisse-gp-healthcare-israel/credit-suisse-commits-250-mln-to-israeli-healthcare-fund-idUSL5N1SM7SH", "ord_in_thread": 0, "title": "Credit Suisse commits $250 mln to Israeli healthcare fund", "locations": [], "entities": {"persons": [{"name": "reut", "sentiment": "negative"}, {"name": "marius nacht", "sentiment": "none"}, {"name": "schindel", "sentiment": "none"}, {"name": "yair schindel", "sentiment": "none"}], "locations": [{"name": "united states", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}, {"name": "israel", "sentiment": "none"}], "organizations": [{"name": "credit suisse", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "check point software technologies", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 16, 2018 / 5:00 AM / Updated 33 minutes ago Credit Suisse commits $250 mln to Israeli healthcare fund Reuters Staff 2 Min Read\nTEL AVIV, May 16 (Reuters) - Israel-based healthcare fund aMoon II has secured a $250 million investment commitment from Credit Suisse, the fund’s managing partner Yair Schindel said on Wednesday.\nLast month the fund, which is investing in mid- to late-stage companies with a focus on fields like digital health, medical technology and biopharma in Israel, the United States and Europe, said it had raised $200 million from private investors.\nThe Credit Suisse financing from its asset management and private banking divisions brings the fund close to meeting its target of $500 million. The remainder of the funding is expected to be raised within a few months from other financial institutions and wealthy individuals.\nThe fund intends to invest $10 million to $40 million in 15 to 20 companies.\naMoon is a life sciences investment fund founded in 2016 by Marius Nacht, co-founder and chairman of Check Point Software Technologies, and Schindel.\nNacht and Schindel’s previous fund, aMoon I, focused on the early stage, investing in 16 startups. (Reporting by Tova Cohen)", "external_links": [], "published": "2018-05-16T08:00:00.000+03:00", "crawled": "2018-05-16T08:12:31.057+03:00", "highlightTitle": ""}